Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: Evidence for proteolysis of cell-surface molecules

Journal of Cellular Physiology

Volumn 168, Issue 3, 1996, Pages 625-637

  Ihrcke, Nathan S ^a   Platt, Jeffrey L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPAIN; CYTOKINE; ENDOTOXIN; HEPARIN; LEUPEPTIN; PROTEINASE INHIBITOR; PROTEOHEPARAN SULFATE; SURAMIN;

ANIMAL CELL; ARTICLE; BLOOD CLOTTING; CELL ACTIVITY; CELL SURFACE; ENDOTHELIUM CELL; HUMORAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANIMALS; ANTIGEN-ANTIBODY REACTIONS; CELLS, CULTURED; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; ENDOTHELIUM, VASCULAR; GLUCURONIDASE; GLYCOSIDE HYDROLASES; HEPARAN SULFATE PROTEOGLYCANS; HEPARITIN SULFATE; MOLECULAR WEIGHT; PROTEOGLYCANS; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS; SOLUBILITY; SWINE;

EID: 0029764505     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199609)168:3<625::AID-JCP15>3.0.CO;2-Y     Document Type: Article

References (62)

1. Abrahamsson, T., Brandt, U., Marklund, S.L., and Sjoquist, P. (1992) Vascular bound recombinant extracellular superoxide dismutase type C protects against the detrimental effects of superoxide radicals on endothelium-dependent arterial relaxation. Circul. Res., 70:264-271.
2. Barr, P. (1991) Mammalian subtilisins: The long-sought dibasic processing endoproteases. Cell, 66:1-3.
3. Bernfield, M., Kokenyesi, R., Kato, M., Hinkes, M.T., Spring, J., Gallo, R.L., and Lose, E.J. (1992) Biology of the syndecans: A family of transmembrane heparan sulfate proteoglycans. Annu. Rev. Cell Biol., 8:365-393.
4. Bevilacqua, M.P., Stengelin, S., Gimbrone, M.A., Jr., and Seed, B. (1989) Endothelial leukocyte adhesion molecule I: An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science, 243:1160-1164.
5. Branden, E., and Hirschberg, C.B. (1989) Differential association of rat liver heparan sulfate proteoglycans in membranes of the golgi apparatus and the plasma membrane. J. Biol. Chem., 264:10520-10526.
6. Cines, D.B. (1989) Disorders associated with antibodies to endothelial cells. Rev. Infect. Diseases, 11:S705-S711.
7. Cines, D.B., Lyss, A.P., Reeber, M., Bina, M., and DeHoratius, R.J. (1984) Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. J. Clin. Invest., 73:611-625.
8. Colburn, P., Kobayashi, E., and Buonassisi, V. (1994) Depleted level of heparan sulfate proteoglycan in the extracellular matrix of endothelial cell cultures exposed to endotoxin. J. Cell. Physiol., 159:121-130.
9. Couchman, J.R. (1987) Heterogeneous distribution of a basement membrane heparan sulfate proteoglycan in rat tissues. J. Cell Biol., 105:1901-1916.
10. Eldor, A., Bar-Ner, M., Yahalom, J., Fuks, Z., and Vlodavsky, I. (1987) Role of heparanase in platelet and tumor cell interactions with the subendothelial extracellular matrix. Sem. Thromb. Hemost., 13:475-488.
11. Esmon, C.T. (1990) The regulation of natural anticoagulant pathways. Science, 235:1348-1352.
12. Fedarko, N.S., Ishihara, M., and Conrad, H.E. (1989) Control of cell division in hepatoma cells by exogenous heparan sulfate proteoglycan. J. Cell. Physiol., 139:287.
13. Galfré, G., and Milstein, C. (1981) Preparation of monoclonal antibodies: Strategies and procedures. Methods Enzymol., 73:3-46.
14. Gallagher, J.T., Walker, A., Lyon, M., and Evans, W.H. (1988) Heparan sulfate-degrading endoglycosidase in liver plasma membranes. Biochem. J., 250:719-726.
15. Geller, R.L., Ihrcke, N.S., Maines, J., Lindman, B.J., and Platt, J.L. (1993) Loss of heparan sulfate proteoglycan as a manifestation of cellular immunity in vivo and in vitro. Transpl. Proc., 25:144-145.
16. Gilat, D., Hershkoviz, R., Goldkorn, I., Cahalon, L., Korner, G., Vlodavsky, I., and Lider, O. (1995) Molecular behavior adapts to context: Heparanase functions as an extracellular matrix-degrading enzyme or as a T-cell adhesion molecule, depending on the local pH. J. Exp. Med., 181:1929-1934.
17. Hamilton, K.K., Hattori, R., Esmon, C.T., and Sims, P.J. (1990) Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J. Biol. Chem., 265:3809-3814.
18. Holzknecht, Z.E., and Platt, J.L. (1995) Identification of porcine endothelial cell membrane antigens recognized by human xenoreactive antibodies. J. Immunol., 154:4565-4575.
19. Hoogewerf, A.J., Leone, J.W., Reardon, I.M., Howe, W.J., Asa, D., Heinrikson, R.L., and Ledbetter, S.R. (1995) CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes. J. Biol. Chem., 270:3268-3277.
20. Ihrcke, N.S., Wrenshall, L.E., Lindman, B.J., and Platt, J.L. (1993) Role of heparan sulfate in immune system-blood vessel interactions. Immunol. Today, 14:500-505.
21. Ishihara, M., Fedarko, N.S., and Conrad, H.E. (1987) Involvement of phosphatidylinositol and insulin in the coordinate regulation of proteoheparan sulfate metabolism and hepatocyte growth. J. Biol. Chem., 262:4708-4716.
22. Jalkanen, M., Rapraeger, A., Caunders, S., and Bernfield, M. (1987) Cell surface proteoglycan of mouse mammary epithelial cells is shed by cleavage of its matrix-binding ectodomain from its membrane-associated domain. J. Cell Biol., 105:3087-3096.
23. Kanwar, Y.S., Linker, A., and Farquhar, M.G. (1980) Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion. J. Cell Biol., 86:688-693.
24. Key, N.S., Platt, J.L., and Vercellotti, G.M. (1992) Vascular endothelial cell proteoglycans are susceptible to cleavage by neutrophils. Arterio. Thromb., 12:836-842.
25. Kjellen, L., Oldberg, A., and Hook, M. (1980) Cell-surface heparan sulfate: Mechanisms of proteoglycan-cell association. J. Biol. Chem., 255:10407-10413.
26. Kobayashi, M., Shimada, K., and Ozawa, T. (1990) Human recombinant interleukin-1β- and tumor necrosis factor α-mediated suppression of heparin-like compounds on cultured porcine aortic endothelial cells. J. Cell. Physiol., 144:383-390.
27. Kojima, T., Shworak, N.W., and Rosenberg, R.D. (1992) Molecular cloning and expression of two distinct cDNA-encoding heparan sulfate proteoglycan core proteins from a rat endothelial cell line. J. Biol. Chem., 267:4870-4877.
28. Kraemer, P.M., and Tobey, R.A. (1972) Cell-cycle dependent desquamation of heparan sulfate from the cell surface. J. Cell Biol., 55:713-717.
29. Mertens, G., Cassiman, J., Van den Berghe, H., Vermylen, J., and David, G. (1992) Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. J. Biol. Chem., 267:20435-20443.
30. Moore, K.L., Andreoli, S.P., Esmon, N.L., Esmon, C.T., and Bang, N.U. (1987) Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J. Clin. Invest., 79:124-130.
31. Moore, K.L., Esmon, C.T., and Esmon, N.L. (1989) Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood, 73:159-165.
32. Morgan, B.P. (1989) Complement membrane attack on nucleated cells: Resistance, recovery and non-lethal effects. Biochem. J., 264:1-14.
33. Murdoch, A.D., Dodge, G.R., Cohen, I., Tuan, R.S., and Iozzo, R.V. (1992) Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG-2/perlecan). J. Biol. Chem., 267:8544-8557.
34. Nachman, R.L., Hajjar, K.A., Silverstein, R.L., and Dinarello, C.A. (1986) Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor. J. Exp. Med., 163:1595-1600.
35. Nakajima, M., Di Ferrante, D., Irimura, T., Di Ferrante, N., and Nicolson, G.L. (1983) Heparan sulfate degradation: Relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. Science, 220:611-612.
36. Nakajima, M., DeChavigny, A., Johnson, C.E., Hamada, J., Stein, C.A., and Nicolson, G.L. (1991) Suramin: A potent inhibitor of melanoma heparanase and invasion. J. Biol. Chem., 266:9661-9666.
37. Naparstek, Y., Cohen, I.R., Fuks, Z., and Vlodavsky, I. (1984) Activated T-lymphocytes produce a matrix-degrading heparan sulfate endoglycosidase. Nature, 310:241-244.
38. Oohira, A., Wight, T.N., and Bornstein, P. (1983) Sulfated proteoglycans synthesized by vascular endothelial cells. J. Biol. Chem., 255:2014-2021.
39. Paulsson, M., Dziadek, M., Suchanek, C., Huttner, W.B., and Timpl, R. (1985) Nature of sulphated macromolecules in mouse Reichert's membrane. Biochem. J., 231:571-579.
40. Paulsson, M., Yurchenco, P.D., Ruben, G.C., Engel, J., and Timpl, R. (1987) Structure of low density heparan sulfate proteoglycan isolated from a mouse tumor basement membrane. J. Mol. Biol., 197:297-313.
41. Platt, J.L., Vercellotti, G.M., Dalmasso, A.P., Matas, A.J., Bolman, R.M., Najarian, J.S., and Bach, F.H. (1990a) Transplantation of discordant xenografts: A review of progress. Immunol. Today, 11:450-456.
42. Platt, J.L., Vercellotti, G.M., Lindman, B.J., Oegema, T.R., Jr., Bach, F.H., and Dalmasso, A.P. (1990b) Release of heparan sulfate from endothelial cells: Implications for pathogenesis of hyperacute rejection. J. Exp. Med., 171:1363-1368.
43. Platt, J.L., Dalmasso, A.P., Lindman, B.J., Ihrcke, N.S., and Bach, F.H. (1991a) The role of C5a and antibody in the release of heparan sulfate from endothelial cells. Eur. J. Immunol., 21:2887-2890.
44. Platt, J.L., Lindman, B.J., Geller, R.L., Noreen, H.J., Swanson, J.L., Dalmasso, A.P., and Bach, F.H. (1991b) The role of natural antibodies in the activation of xenogenic endothelial cells. Transplantation, 52:1037-1043.
45. Pober, J.S., and Cotran, R.S. (1990) Cytokines and endothelial cell biology. Physiol. Rev., 70:427-451.
46. Ramasamy, S., Lipke, D.W., McClain, C.J., and Hennig, B. (1995) Tumor necrosis factor reduces proteoglycan synthesis in cultured endothelial cells. J. Cell. Physiol., 162:119-126.
47. Rapaport, S.I. (1991) The extrinsic pathway inhibitor: A regulator of tissue factor-dependent blood coagulation. Thromb. Haemostasis, 66:6-15.
48. Rosenberg, R.D., and Rosenberg, J.S. (1984) Natural anticoagulent mechanisms. J. Clin. Invest., 74:1-6.
49. Ryan, U.S., and Maxwell, G. (1986) Isolation, culture and subculture of endothelial cells: Mechanical methods. J. Tissue Culture Methods, 10:3-5.
50. Saadi, S., Holzkhecht, R.A., Patte, C.P., Stern, D.M., and Platt, J.L. (1995) Complement-mediated regulation of tissue factor activity in endothelium, J. Exp. Med., 182:1807-1814.
51. Saksela, O., and Rifkin, D. (1990) Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J. Cell Biol., 110:767-775.
52. Seidah, N.G., Chretien, M., and Day, R. (1994) The family of subtilisin/ kexin like pro-protein and pro-hormone convertases: Divergent or shared functions. Biochimie, 76:197-209.
53. Stevens, R.B., Wang, Y.L., Kaji, H., Lloveras, J., Dalmasso, A.B., Bach, F.H., Rubinstein, P., Sutherland, D.E.R., and Platt, J.L. (1993) Administration of nonanticoagulant heparin inhibits the loss of glycosaminoglycans from xenogeneic cardiac grafts and prolongs graft survival. Transpl. Proc., 25:382.
54. Tanaka, Y., Adams, D., and Shaw, S. (1993) Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol. Today, 14:111-115.
55. Vlodavsky, I., Lui, G.M., and Gospodarowicz, D. (1980) Morphological appearance, growth behavior and migratory activity of human tumor cells maintained on extracellular matrix versus plastic. Cell, 19:607-616.
56. Vlodavsky, I., Eldor, A., Haimovitz-Friedman, A., Ishai-Michaeli, R., Lider, O., Naparstek, Y., Cohen, I.R., and Fuks, Z. (1992) Expression of heparanase by platelets and circulating cells of the immune system: Possible involvement in diapedesis and extravasation. Invasion Metastasis, 12:112-127.
57. Wasteson, A. (1971) A method for the determination of the molecular weight and molecular-weight distribution of chondroitin sulphate. J. Chromatog., 59:87-97.
58. Webb, L.M.C., Ehrengruber, M.U., Clark-Lewis, I., Baggiolini, M., and Rot, A. (1993) Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin-8. Proc. Natl. Acad. Sci. USA, 90:7158-7162.
59. Weiler, J.M., and Linhardt, R.J. (1991) Antithrombin III regulates complement activity in vitro. J. Immunol., 146:3889-3894.
60. Wrenshall, L.E., Cerra, F.B., Carlson, A., Bach, F.H., and Platt, J.L. (1991) Regulation of murine splenocyte responses by heparan sulfate. J. Immunol., 147:455-459.
61. Wrenshall, L.E., Carlson, A., Cerra, F.B., and Platt, J.L. (1994) Modulation of cytolytic T-cell responses by heparan sulfate. Transplantation, 57:1087-1094.
62. Wrenshall, L.E., Cerra, F.B., Singh, R.K., and Platt, J.L. (1995) Heparan sulfate initiates signals in murine macrophages leading to divergent biological outcomes. J. Immunol., 154:871-880.